FindTrial
Sign In

Evaluation of the effect of FYX-051 on cardiac repolarization : a thorough QT/QTc study.

Evaluation of the effect of FYX-051 on cardiac repolarization : a thorough QT/QTc study.

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221352
Enrollment
48
Registered
2011-01-15
Start date
2011-01-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult subjects

Interventions

investigational material(s) Generic name etc : FYX-051 INN of investigational material : Therapeutic category code : 394 Agents for treatment of gout Dosage and Administration for Investigational mat

Sponsors

SANWA KAGAKU KENKYUSHO CO.,LTD.
Lead Sponsor
Fuji Yakuhin Co., Ltd.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Japanese healthy adult subjects Body weight:male 50kg or more, female 40kg or more

Exclusion criteria

Exclusion criteria: Subjects with any disease or any history of diseases that might be unsuitable for participation in the clinical study

Design outcomes

Primary

MeasureTime frame
Pharmacodynamics, Pharmacokinetics and Safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026